Načítá se...
Liraglutide is effective in type 2 diabetic patients with sustained endogenous insulin‐secreting capacity
Aims/Introduction: Recently, glucagon‐like peptide‐1 (GLP‐1) receptor agonists of liraglutide have become available in Japan. It has not yet been clarified what clinical parameters could discriminate liraglutide‐effective patients from liraglutide‐ineffective patients. Materials and Methods: We re...
Uloženo v:
Hlavní autoři: | , , , , , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Blackwell Publishing Ltd
2012
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4014952/ https://ncbi.nlm.nih.gov/pubmed/24843579 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.2040-1124.2011.00168.x |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|